Global Nucleic Acid Amplification Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 174310
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Nucleic Acid Amplification Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nucleic Acid Amplification Testing size is estimated to be USD 159.1 million in 2025 from USD 135.3 million in 2019, with a change XX% between 2019 and 2020. The global Nucleic Acid Amplification Testing market size is expected to grow at a CAGR of 4.1% for the next five years.

Market segmentation

Nucleic Acid Amplification Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Target Amplification Systems

Probe Amplification Systems

Signal Amplification

Market segment by Application, can be divided into

Infectious Diseases

Cancer

Personalized Medicine

Genetic and Mitochondrial Disorders

Market segment by players, this report covers

F. Hoffmann-La Roche

Becton

Dickinson and Company

Beckman Coulter

Abbott Laboratories

Illumina

Siemens Healthineers

bioMerieux

Novartis

Bio-Rad Laboratories

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Nucleic Acid Amplification Testing

1.2 Classification of Nucleic Acid Amplification Testing by Type

1.2.1 Overview: Global Nucleic Acid Amplification Testing Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Nucleic Acid Amplification Testing Revenue Market Share by Type in 2020

1.2.3 Target Amplification Systems

1.2.4 Probe Amplification Systems

1.2.5 Signal Amplification

1.3 Global Nucleic Acid Amplification Testing Market by Application

1.3.1 Overview: Global Nucleic Acid Amplification Testing Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Infectious Diseases

1.3.3 Cancer

1.3.4 Personalized Medicine

1.3.5 Genetic and Mitochondrial Disorders

1.4 Global Nucleic Acid Amplification Testing Market Size & Forecast

1.5 Global Nucleic Acid Amplification Testing Market Size and Forecast by Region

1.5.1 Global Nucleic Acid Amplification Testing Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Nucleic Acid Amplification Testing Market Size by Region, (2016-2021)

1.5.3 North America Nucleic Acid Amplification Testing Market Size and Prospect (2016-2026)

1.5.4 Europe Nucleic Acid Amplification Testing Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Nucleic Acid Amplification Testing Market Size and Prospect (2016-2026)

1.5.6 South America Nucleic Acid Amplification Testing Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Nucleic Acid Amplification Testing Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Nucleic Acid Amplification Testing Market Drivers

1.6.2 Nucleic Acid Amplification Testing Market Restraints

1.6.3 Nucleic Acid Amplification Testing Trends Analysis

2 Company Profiles

2.1 F. Hoffmann-La Roche

2.1.1 F. Hoffmann-La Roche Details

2.1.2 F. Hoffmann-La Roche Major Business

2.1.3 F. Hoffmann-La Roche Nucleic Acid Amplification Testing Product and Solutions

2.1.4 F. Hoffmann-La Roche Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 F. Hoffmann-La Roche Recent Developments and Future Plans

2.2 Becton

2.2.1 Becton Details

2.2.2 Becton Major Business

2.2.3 Becton Nucleic Acid Amplification Testing Product and Solutions

2.2.4 Becton Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Becton Recent Developments and Future Plans

2.3 Dickinson and Company

2.3.1 Dickinson and Company Details

2.3.2 Dickinson and Company Major Business

2.3.3 Dickinson and Company Nucleic Acid Amplification Testing Product and Solutions

2.3.4 Dickinson and Company Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Dickinson and Company Recent Developments and Future Plans

2.4 Beckman Coulter

2.4.1 Beckman Coulter Details

2.4.2 Beckman Coulter Major Business

2.4.3 Beckman Coulter Nucleic Acid Amplification Testing Product and Solutions

2.4.4 Beckman Coulter Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Beckman Coulter Recent Developments and Future Plans

2.5 Abbott Laboratories

2.5.1 Abbott Laboratories Details

2.5.2 Abbott Laboratories Major Business

2.5.3 Abbott Laboratories Nucleic Acid Amplification Testing Product and Solutions

2.5.4 Abbott Laboratories Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Abbott Laboratories Recent Developments and Future Plans

2.6 Illumina

2.6.1 Illumina Details

2.6.2 Illumina Major Business

2.6.3 Illumina Nucleic Acid Amplification Testing Product and Solutions

2.6.4 Illumina Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Illumina Recent Developments and Future Plans

2.7 Siemens Healthineers

2.7.1 Siemens Healthineers Details

2.7.2 Siemens Healthineers Major Business

2.7.3 Siemens Healthineers Nucleic Acid Amplification Testing Product and Solutions

2.7.4 Siemens Healthineers Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Siemens Healthineers Recent Developments and Future Plans

2.8 bioMerieux

2.8.1 bioMerieux Details

2.8.2 bioMerieux Major Business

2.8.3 bioMerieux Nucleic Acid Amplification Testing Product and Solutions

2.8.4 bioMerieux Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 bioMerieux Recent Developments and Future Plans

2.9 Novartis

2.9.1 Novartis Details

2.9.2 Novartis Major Business

2.9.3 Novartis Nucleic Acid Amplification Testing Product and Solutions

2.9.4 Novartis Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Novartis Recent Developments and Future Plans

2.10 Bio-Rad Laboratories

2.10.1 Bio-Rad Laboratories Details

2.10.2 Bio-Rad Laboratories Major Business

2.10.3 Bio-Rad Laboratories Nucleic Acid Amplification Testing Product and Solutions

2.10.4 Bio-Rad Laboratories Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Nucleic Acid Amplification Testing Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 Nucleic Acid Amplification Testing Players Market Share

3.2.2 Top 10 Nucleic Acid Amplification Testing Players Market Share

3.2.3 Market Competition Trend

3.3 Nucleic Acid Amplification Testing Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Nucleic Acid Amplification Testing Revenue and Market Share by Type (2016-2021)

4.2 Global Nucleic Acid Amplification Testing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Nucleic Acid Amplification Testing Revenue Market Share by Application (2016-2021)

5.2 Nucleic Acid Amplification Testing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Nucleic Acid Amplification Testing Revenue by Type (2016-2026)

6.2 North America Nucleic Acid Amplification Testing Revenue by Application (2016-2026)

6.3 North America Nucleic Acid Amplification Testing Market Size by Country

6.3.1 North America Nucleic Acid Amplification Testing Revenue by Country (2016-2026)

6.3.2 United States Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

6.3.3 Canada Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

6.3.4 Mexico Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Nucleic Acid Amplification Testing Revenue by Type (2016-2026)

7.2 Europe Nucleic Acid Amplification Testing Revenue by Application (2016-2026)

7.3 Europe Nucleic Acid Amplification Testing Market Size by Country

7.3.1 Europe Nucleic Acid Amplification Testing Revenue by Country (2016-2026)

7.3.2 Germany Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

7.3.3 France Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

7.3.5 Russia Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

7.3.6 Italy Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Nucleic Acid Amplification Testing Revenue by Type (2016-2026)

8.2 Asia-Pacific Nucleic Acid Amplification Testing Revenue by Application (2016-2026)

8.3 Asia-Pacific Nucleic Acid Amplification Testing Market Size by Region

8.3.1 Asia-Pacific Nucleic Acid Amplification Testing Revenue by Region (2016-2026)

8.3.2 China Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

8.3.3 Japan Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

8.3.4 South Korea Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

8.3.5 India Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

8.3.7 Australia Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Nucleic Acid Amplification Testing Revenue by Type (2016-2026)

9.2 South America Nucleic Acid Amplification Testing Revenue by Application (2016-2026)

9.3 South America Nucleic Acid Amplification Testing Market Size by Country

9.3.1 South America Nucleic Acid Amplification Testing Revenue by Country (2016-2026)

9.3.2 Brazil Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

9.3.3 Argentina Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Nucleic Acid Amplification Testing Revenue by Type (2016-2026)

10.2 Middle East & Africa Nucleic Acid Amplification Testing Revenue by Application (2016-2026)

10.3 Middle East & Africa Nucleic Acid Amplification Testing Market Size by Country

10.3.1 Middle East & Africa Nucleic Acid Amplification Testing Revenue by Country (2016-2026)

10.3.2 Turkey Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

10.3.4 UAE Nucleic Acid Amplification Testing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Nucleic Acid Amplification Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Nucleic Acid Amplification Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Nucleic Acid Amplification Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Nucleic Acid Amplification Testing Revenue (USD Million) by Region (2016-2021)

Table 5. Global Nucleic Acid Amplification Testing Revenue Market Share by Region (2021-2026)

Table 6. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 7. F. Hoffmann-La Roche Major Business

Table 8. F. Hoffmann-La Roche Nucleic Acid Amplification Testing Product and Solutions

Table 9. F. Hoffmann-La Roche Nucleic Acid Amplification Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Becton Corporate Information, Head Office, and Major Competitors

Table 11. Becton Major Business

Table 12. Becton Nucleic Acid Amplification Testing Product and Solutions

Table 13. Becton Nucleic Acid Amplification Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Dickinson and Company Corporate Information, Head Office, and Major Competitors

Table 15. Dickinson and Company Major Business

Table 16. Dickinson and Company Nucleic Acid Amplification Testing Product and Solutions

Table 17. Dickinson and Company Nucleic Acid Amplification Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Beckman Coulter Corporate Information, Head Office, and Major Competitors

Table 19. Beckman Coulter Major Business

Table 20. Beckman Coulter Nucleic Acid Amplification Testing Product and Solutions

Table 21. Beckman Coulter Nucleic Acid Amplification Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 23. Abbott Laboratories Major Business

Table 24. Abbott Laboratories Nucleic Acid Amplification Testing Product and Solutions

Table 25. Abbott Laboratories Nucleic Acid Amplification Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Illumina Corporate Information, Head Office, and Major Competitors

Table 27. Illumina Major Business

Table 28. Illumina Nucleic Acid Amplification Testing Product and Solutions

Table 29. Illumina Nucleic Acid Amplification Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Siemens Healthineers Corporate Information, Head Office, and Major Competitors

Table 31. Siemens Healthineers Major Business

Table 32. Siemens Healthineers Nucleic Acid Amplification Testing Product and Solutions

Table 33. Siemens Healthineers Nucleic Acid Amplification Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. bioMerieux Corporate Information, Head Office, and Major Competitors

Table 35. bioMerieux Major Business

Table 36. bioMerieux Nucleic Acid Amplification Testing Product and Solutions

Table 37. bioMerieux Nucleic Acid Amplification Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Novartis Corporate Information, Head Office, and Major Competitors

Table 39. Novartis Major Business

Table 40. Novartis Nucleic Acid Amplification Testing Product and Solutions

Table 41. Novartis Nucleic Acid Amplification Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 43. Bio-Rad Laboratories Major Business

Table 44. Bio-Rad Laboratories Nucleic Acid Amplification Testing Product and Solutions

Table 45. Bio-Rad Laboratories Nucleic Acid Amplification Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Global Nucleic Acid Amplification Testing Revenue (USD Million) by Players (2019-2021)

Table 47. Global Nucleic Acid Amplification Testing Revenue Share by Players (2019-2021)

Table 48. Breakdown of Nucleic Acid Amplification Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Nucleic Acid Amplification Testing Players Head Office, Products and Services Provided

Table 50. Nucleic Acid Amplification Testing Mergers & Acquisitions in the Past Five Years

Table 51. Nucleic Acid Amplification Testing New Entrants and Expansion Plans

Table 52. Global Nucleic Acid Amplification Testing Revenue (USD Million) by Type (2016-2021)

Table 53. Global Nucleic Acid Amplification Testing Revenue Share by Type (2016-2021)

Table 54. Global Nucleic Acid Amplification Testing Revenue Forecast by Type (2021-2026)

Table 55. Global Nucleic Acid Amplification Testing Revenue by Application (2016-2021)

Table 56. Global Nucleic Acid Amplification Testing Revenue Forecast by Application (2021-2026)

Table 57. North America Nucleic Acid Amplification Testing Revenue by Type (2016-2021) & (USD Million)

Table 58. North America Nucleic Acid Amplification Testing Revenue by Type (2021-2026) & (USD Million)

Table 59. North America Nucleic Acid Amplification Testing Revenue by Application (2016-2021) & (USD Million)

Table 60. North America Nucleic Acid Amplification Testing Revenue by Application (2021-2026) & (USD Million)

Table 61. North America Nucleic Acid Amplification Testing Revenue by Country (2016-2021) & (USD Million)

Table 62. North America Nucleic Acid Amplification Testing Revenue by Country (2021-2026) & (USD Million)

Table 63. Europe Nucleic Acid Amplification Testing Revenue by Type (2016-2021) & (USD Million)

Table 64. Europe Nucleic Acid Amplification Testing Revenue by Type (2021-2026) & (USD Million)

Table 65. Europe Nucleic Acid Amplification Testing Revenue by Application (2016-2021) & (USD Million)

Table 66. Europe Nucleic Acid Amplification Testing Revenue by Application (2021-2026) & (USD Million)

Table 67. Europe Nucleic Acid Amplification Testing Revenue by Country (2016-2021) & (USD Million)

Table 68. Europe Nucleic Acid Amplification Testing Revenue by Country (2021-2026) & (USD Million)

Table 69. Asia-Pacific Nucleic Acid Amplification Testing Revenue by Type (2016-2021) & (USD Million)

Table 70. Asia-Pacific Nucleic Acid Amplification Testing Revenue by Type (2021-2026) & (USD Million)

Table 71. Asia-Pacific Nucleic Acid Amplification Testing Revenue by Application (2016-2021) & (USD Million)

Table 72. Asia-Pacific Nucleic Acid Amplification Testing Revenue by Application (2021-2026) & (USD Million)

Table 73. Asia-Pacific Nucleic Acid Amplification Testing Revenue by Region (2016-2021) & (USD Million)

Table 74. Asia-Pacific Nucleic Acid Amplification Testing Revenue by Region (2021-2026) & (USD Million)

Table 75. South America Nucleic Acid Amplification Testing Revenue by Type (2016-2021) & (USD Million)

Table 76. South America Nucleic Acid Amplification Testing Revenue by Type (2021-2026) & (USD Million)

Table 77. South America Nucleic Acid Amplification Testing Revenue by Application (2016-2021) & (USD Million)

Table 78. South America Nucleic Acid Amplification Testing Revenue by Application (2021-2026) & (USD Million)

Table 79. South America Nucleic Acid Amplification Testing Revenue by Country (2016-2021) & (USD Million)

Table 80. South America Nucleic Acid Amplification Testing Revenue by Country (2021-2026) & (USD Million)

Table 81. Middle East & Africa Nucleic Acid Amplification Testing Revenue by Type (2016-2021) & (USD Million)

Table 82. Middle East & Africa Nucleic Acid Amplification Testing Revenue by Type (2021-2026) & (USD Million)

Table 83. Middle East & Africa Nucleic Acid Amplification Testing Revenue by Application (2016-2021) & (USD Million)

Table 84. Middle East & Africa Nucleic Acid Amplification Testing Revenue by Application (2021-2026) & (USD Million)

Table 85. Middle East & Africa Nucleic Acid Amplification Testing Revenue by Country (2016-2021) & (USD Million)

Table 86. Middle East & Africa Nucleic Acid Amplification Testing Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Nucleic Acid Amplification Testing Picture

Figure 2. Global Nucleic Acid Amplification Testing Revenue Market Share by Type in 2020

Figure 3. Target Amplification Systems

Figure 4. Probe Amplification Systems

Figure 5. Signal Amplification

Figure 6. Nucleic Acid Amplification Testing Revenue Market Share by Application in 2020

Figure 7. Infectious Diseases Picture

Figure 8. Cancer Picture

Figure 9. Personalized Medicine Picture

Figure 10. Genetic and Mitochondrial Disorders Picture

Figure 11. Global Nucleic Acid Amplification Testing Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Nucleic Acid Amplification Testing Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Nucleic Acid Amplification Testing Revenue Market Share by Region (2016-2026)

Figure 14. Global Nucleic Acid Amplification Testing Revenue Market Share by Region in 2020

Figure 15. North America Nucleic Acid Amplification Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Nucleic Acid Amplification Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Nucleic Acid Amplification Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Nucleic Acid Amplification Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Nucleic Acid Amplification Testing Market Drivers

Figure 20. Nucleic Acid Amplification Testing Market Restraints

Figure 21. Nucleic Acid Amplification Testing Market Trends

Figure 22. F. Hoffmann-La Roche Recent Developments and Future Plans

Figure 23. Becton Recent Developments and Future Plans

Figure 24. Dickinson and Company Recent Developments and Future Plans

Figure 25. Beckman Coulter Recent Developments and Future Plans

Figure 26. Abbott Laboratories Recent Developments and Future Plans

Figure 27. Illumina Recent Developments and Future Plans

Figure 28. Siemens Healthineers Recent Developments and Future Plans

Figure 29. bioMerieux Recent Developments and Future Plans

Figure 30. Novartis Recent Developments and Future Plans

Figure 31. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 33. Global Nucleic Acid Amplification Testing Revenue Share by Players in 2020

Figure 34. Nucleic Acid Amplification Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 35. Global Top 3 Players Nucleic Acid Amplification Testing Revenue Market Share in 2020

Figure 36. Global Top 10 Players Nucleic Acid Amplification Testing Revenue Market Share in 2020

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 38. Global Nucleic Acid Amplification Testing Revenue Share by Type in 2020

Figure 39. Global Nucleic Acid Amplification Testing Market Share Forecast by Type (2021-2026)

Figure 40. Global Nucleic Acid Amplification Testing Revenue Share by Application in 2020

Figure 41. Global Nucleic Acid Amplification Testing Market Share Forecast by Application (2021-2026)

Figure 42. North America Nucleic Acid Amplification Testing Sales Market Share by Type (2016-2026)

Figure 43. North America Nucleic Acid Amplification Testing Sales Market Share by Application (2016-2026)

Figure 44. North America Nucleic Acid Amplification Testing Revenue Market Share by Country (2016-2026)

Figure 45. United States Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Canada Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Mexico Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Europe Nucleic Acid Amplification Testing Sales Market Share by Type (2016-2026)

Figure 49. Europe Nucleic Acid Amplification Testing Sales Market Share by Application (2016-2026)

Figure 50. Europe Nucleic Acid Amplification Testing Revenue Market Share by Country (2016-2026)

Figure 51. Germany Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. France Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. United Kingdom Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Russia Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Italy Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Asia-Pacific Nucleic Acid Amplification Testing Sales Market Share by Type (2016-2026)

Figure 57. Asia-Pacific Nucleic Acid Amplification Testing Sales Market Share by Application (2016-2026)

Figure 58. Asia-Pacific Nucleic Acid Amplification Testing Revenue Market Share by Region (2016-2026)

Figure 59. China Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Japan Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South Korea Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. India Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Southeast Asia Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Australia Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South America Nucleic Acid Amplification Testing Sales Market Share by Type (2016-2026)

Figure 66. South America Nucleic Acid Amplification Testing Sales Market Share by Application (2016-2026)

Figure 67. South America Nucleic Acid Amplification Testing Revenue Market Share by Country (2016-2026)

Figure 68. Brazil Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East and Africa Nucleic Acid Amplification Testing Sales Market Share by Type (2016-2026)

Figure 71. Middle East and Africa Nucleic Acid Amplification Testing Sales Market Share by Application (2016-2026)

Figure 72. Middle East and Africa Nucleic Acid Amplification Testing Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. UAE Nucleic Acid Amplification Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz